Effect of Baduanjin in Elderly Individuals

NCT06630533 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-12-04

No results posted yet for this study

Summary

Aging is a biological process that begins with the birth of individuals and continues until death. With increasing age, the human body enters a process in which structural and functional changes occur and may differ between individuals. This study aims to determine the effect of Baduanji by reducing or completely eliminating the risk of loss of balance and falls in elderly individuals. 60 people between the ages of 65-85 will be included in the study. Individuals will be randomly divided into two groups. In the study, the Berg Balance Scale (BDS) was used to assess balance and the Timed Up and Go Test (TUGT) test was used to assess functional levels. In our study, the Baduanjin exercise program will be applied 5 days a week for 8 weeks with the supervision of a physiotherapist. The Baduanjin exercise program will be applied to the first group, the second group will be the control group and no intervention will be made.

Conditions

  • Exercise

Interventions

OTHER

Baduanjin Exercise Group

Baduanjin exercises (Eight-Part Exercises or Eight-Part Brocades), an important part of Qigong, consist of eight postures (1-holding the hands high with palms up, 2- posing as an archer shooting, 3- holding one arm aloft, 4- looking backwards, 5- swinging the head and lowering the body, 6- moving the hands down the back and legs and touching the feet, 7- thrusting the fists and making the eyes glare, and 8- raising and lowering the heels).

Sponsors & Collaborators

  • Biruni University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-01
Primary Completion
2024-12-01
Completion
2024-12-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06630533 on ClinicalTrials.gov